Currently, Orchestra BioMed Holdings Inc [OBIO] is trading at $5.37, down -4.45%. An important factor to consider is whether the stock is rising or falling in short-term value. The OBIO shares have gain 34.25% over the last week, with a monthly amount glided 6.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Orchestra BioMed Holdings Inc [NASDAQ: OBIO] stock has seen the most recent analyst activity on January 02, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $16. Previously, H.C. Wainwright started tracking the stock with Buy rating on August 22, 2024, and set its price target to $14. On July 25, 2024, B. Riley Securities initiated with a Buy rating and assigned a price target of $15 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $14 on January 19, 2024. Piper Sandler initiated its recommendation with a Overweight and recommended $15 as its price target on February 24, 2023. Chardan Capital Markets started tracking with a Buy rating for this stock on February 07, 2023, and assigned it a price target of $20.
This stock has fluctuated between a low of $3.96 and a high of $10.06 over the last 52 weeks. Orchestra BioMed Holdings Inc [NASDAQ: OBIO] shares were valued at $5.37 at the most recent close of the market.
Analyzing the OBIO fundamentals
Trailing Twelve Months sales for Orchestra BioMed Holdings Inc [NASDAQ:OBIO] were 2.65M which represents 135.56% growth. Gross Profit Margin for this corporation currently stands at 0.89% with Operating Profit Margin at -22.71%, Pretax Profit Margin comes in at -21.79%, and Net Profit Margin reading is -21.79%. To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -1.07 and Total Capital is -1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.21 points at the first support level, and at 5.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.62, and for the 2nd resistance point, it is at 5.86.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Orchestra BioMed Holdings Inc [NASDAQ:OBIO] is 4.23. On the other hand, the Quick Ratio is 4.21, and the Cash Ratio is 1.58. Considering the valuation of this stock, the price to sales ratio is 77.03, the price to book ratio is 4.41.
Transactions by insiders
Recent insider trading involved Hochman David P, that happened on Dec 23 ’24 when 4000.0 shares were purchased. Chief Financial Officer, Taylor Andrew Lawrence completed a deal on Dec 19 ’24 to buy 1000.0 shares. Meanwhile, Hochman David P bought 5000.0 shares on Dec 18 ’24.
